Literature DB >> 19660283

Treatment of heparin-induced thrombocytopenia after cardiac surgery: preliminary experience with fondaparinux.

Federico Pappalardo1, Annamara Scandroglio, Giulia Maj, Alberto Zangrillo, Armando D'Angelo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19660283     DOI： 10.1016/j.jtcvs.2008.11.032

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN： 0022-5223            Impact factor:   5.209


× No keyword cloud information.
  5 in total

1.  Randomized trial of fondaparinux versus heparin to prevent graft failure after coronary artery bypass grafting: the Fonda CABG study.

Authors:  Jack C J Sun; Kevin H T Teoh; Tej Sheth; David Landry; Hyejung Jung; Theodore E Warkentin; Salim Yusuf; Andre Lamy; John W Eikelboom
Journal:  J Thromb Thrombolysis       Date:  2011-10       Impact factor: 2.300

Review 2.  Heparin induced thrombocytopenia in critically ill: Diagnostic dilemmas and management conundrums.

Authors:  Sachin Gupta; Ravindranath Tiruvoipati; Cameron Green; John Botha; Huy Tran
Journal:  World J Crit Care Med       Date:  2015-08-04

Review 3.  Heparin Induced Thrombocytopenia for the Perioperative and Critical Care Clinician.

Authors:  Ingrid Moreno-Duarte; Kamrouz Ghadimi
Journal:  Curr Anesthesiol Rep       Date:  2020-08-29

4.  Fondaparinux: another potential treatment for heparin-induced thrombocytopenia type II?

Authors:  Patrick M Honore; Rita Jacobs; Inne Hendrickx; Elisabeth De Waele; Viola Van Gorp; Herbert D Spapen
Journal:  Crit Care       Date:  2016-01-27       Impact factor: 9.097

5.  Systematic review of fondaparinux for heparin-induced thrombocytopenia: When there are no randomized controlled trials.

Authors:  Lori-Ann Linkins; George Hu; Theodore E Warkentin
Journal:  Res Pract Thromb Haemost       Date:  2018-08-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.